Crystal Pharmatech completes ELDICO ED-1 installation; Dedicated MicroED now in routine service
Crystal Pharmatech, a science-driven CRO/CDMO specializing in solid-state research, preformulation studies, and formulation development and manufacturing for small-molecule drugs, today announced that installation of the ELDICO ED-1 electron diffractometer at its Suzhou, China R&D center is complete.
Read original article on The Medical News →Related news
-
A weight-loss drug eased knee arthritis pain in two major trials
United Kingdom
-
Brain's 'cleanup' molecule could aid recovery after stroke
United Kingdom
-
Blood proteins that may predict brain and cardiovascular health issues identified
United Kingdom
-
Researchers detect signs of neuronal damage in the earliest stage of Huntington's disease
United Kingdom
-
Patient comfort with AI-driven health care hinges on provider oversight
United Kingdom
-
Experimental drug eliminates 75% of aggressive pancreatic tumors and enhances immune system memory
United Kingdom
-
Gas prices dip below $4 but inflation remains stubbornly high
United States
-
Martian Volcanic Discovery Could Be ‘Smoking Gun’ in Search for Life
United Kingdom